PF-07868489
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-07868489, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension [Phase 1, Phase 2]